851 related articles for article (PubMed ID: 30678377)
1. The Preclinical and Clinical Progress of Bacteriophages and Their Lytic Enzymes: The Parts are Easier than the Whole.
Abdelkader K; Gerstmans H; Saafan A; Dishisha T; Briers Y
Viruses; 2019 Jan; 11(2):. PubMed ID: 30678377
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.
Dąbrowska K; Abedon ST
Microbiol Mol Biol Rev; 2019 Nov; 83(4):. PubMed ID: 31666296
[TBL] [Abstract][Full Text] [Related]
3. Phage therapy for respiratory infections.
Chang RYK; Wallin M; Lin Y; Leung SSY; Wang H; Morales S; Chan HK
Adv Drug Deliv Rev; 2018 Aug; 133():76-86. PubMed ID: 30096336
[TBL] [Abstract][Full Text] [Related]
4. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
Viertel TM; Ritter K; Horz HP
J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
[TBL] [Abstract][Full Text] [Related]
5. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy.
Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A
Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779
[TBL] [Abstract][Full Text] [Related]
6. Molecular Machinery of the Triad Holin, Endolysin, and Spanin: Key Players Orchestrating Bacteriophage-Induced Cell Lysis and their Therapeutic Applications.
Samir S
Protein Pept Lett; 2024; 31(2):85-96. PubMed ID: 38258777
[TBL] [Abstract][Full Text] [Related]
7. Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.
Cisek AA; Dąbrowska I; Gregorczyk KP; Wyżewski Z
Curr Microbiol; 2017 Feb; 74(2):277-283. PubMed ID: 27896482
[TBL] [Abstract][Full Text] [Related]
8. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields.
Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA
J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461
[TBL] [Abstract][Full Text] [Related]
9. Diversity of phage infection types and associated terminology: the problem with 'Lytic or lysogenic'.
Hobbs Z; Abedon ST
FEMS Microbiol Lett; 2016 Apr; 363(7):. PubMed ID: 26925588
[TBL] [Abstract][Full Text] [Related]
10. Phage Therapy in the Twenty-First Century: Facing the Decline of the Antibiotic Era; Is It Finally Time for the Age of the Phage?
Hesse S; Adhya S
Annu Rev Microbiol; 2019 Sep; 73():155-174. PubMed ID: 31185183
[TBL] [Abstract][Full Text] [Related]
11. Ameliorating the antimicrobial resistance crisis: phage therapy.
Saha D; Mukherjee R
IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
[TBL] [Abstract][Full Text] [Related]
12. Bacteriophage endolysins as a novel class of antibacterial agents.
Borysowski J; Weber-Dabrowska B; Górski A
Exp Biol Med (Maywood); 2006 Apr; 231(4):366-77. PubMed ID: 16565432
[TBL] [Abstract][Full Text] [Related]
13. Promises and Pitfalls of In Vivo Evolution to Improve Phage Therapy.
Bull JJ; Levin BR; Molineux IJ
Viruses; 2019 Nov; 11(12):. PubMed ID: 31766537
[TBL] [Abstract][Full Text] [Related]
14. A Multiwell-Plate Caenorhabditis elegans Assay for Assessing the Therapeutic Potential of Bacteriophages against Clinical Pathogens.
Manohar P; Loh B; Elangovan N; Loganathan A; Nachimuthu R; Leptihn S
Microbiol Spectr; 2022 Feb; 10(1):e0139321. PubMed ID: 35171008
[TBL] [Abstract][Full Text] [Related]
15. Bacteriophages and phage-derived proteins--application approaches.
Drulis-Kawa Z; Majkowska-Skrobek G; Maciejewska B
Curr Med Chem; 2015; 22(14):1757-73. PubMed ID: 25666799
[TBL] [Abstract][Full Text] [Related]
16. Back to the future: bacteriophages as promising therapeutic tools.
Domingo-Calap P; Georgel P; Bahram S
HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
[TBL] [Abstract][Full Text] [Related]
17. Phage Therapy: Going Temperate?
Monteiro R; Pires DP; Costa AR; Azeredo J
Trends Microbiol; 2019 Apr; 27(4):368-378. PubMed ID: 30466900
[TBL] [Abstract][Full Text] [Related]
18. Expression of a Peptidoglycan Hydrolase from Lytic Bacteriophages Atu_ph02 and Atu_ph03 Triggers Lysis of Agrobacterium tumefaciens.
Attai H; Rimbey J; Smith GP; Brown PJB
Appl Environ Microbiol; 2017 Dec; 83(23):. PubMed ID: 28970228
[TBL] [Abstract][Full Text] [Related]
19. Preclinical data and safety assessment of phage therapy in humans.
Nale JY; Clokie MR
Curr Opin Biotechnol; 2021 Apr; 68():310-317. PubMed ID: 33862490
[TBL] [Abstract][Full Text] [Related]
20. Phages Needed against Resistant Bacteria.
Moelling K
Viruses; 2020 Jul; 12(7):. PubMed ID: 32664292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
